ZAMBIAFactsheet of Health Statistics

2018

Overview of UHC and the SDGs

Notes:

Countries assessments of progress towards UHC and SDGs are based onUHC and SDGs index according to the following thresholds: On track(green map): if UHC and SDGs index is equal or more than 75%. Makingprogress (yellow map): if UHC and SDGs index is more than 50% andless than 75%. Insufficient progress (red map): if UHC and SDGs index isless than 50%.

3.1 Maternal mortality

Target 3.1. Reduce the global maternal mortality ratio to less than 70 per 100 000 live births

Indicator Baselinevalue (2015)

Currentvalue (2016)

Projected (1)value(2030)

Target value(2030)

Maternal mortality ratio(per 100 000 live births)

Births attended by skilledhealth personnel (%) 90.0

70.0

75.8

125.6

64.064.0

224.0

Comment Colourcode (2)

The trend during MDG period is towardsgood decline, but pace is not enough tomeet the SDG target. An annual reductionof 7.8% is required to achieve the 2030target.

The trend during MDG period is towardsgood decline, but pace is not enough tomeet the SDG target. An annual reductionof 2.5% is required to achieve the 2030target.

3.2 Newborn and child mortality

Target 3.2. End preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduceneonatal mortality to at least as low as 12 per 1000 live births and under-five mortality to at least as low as 25 per 1000live births

Indicator Baselinevalue (2015)

Currentvalue (2016)

Projected (1)value(2030)

Target value(2030)

Under-five mortality rate(per 1000 live births)

Neonatal mortality rate(per 1000 live births)

Infants receiving threedoses of hepatitis Bvaccine (%)

100.0

12.0

25.0

97.1

15.0

27.4

22.9

63.4

90.0

23.4

66.1

Comment Colourcode (2)

The trend during MDG period is towardsgood decline, but pace is not enough tomeet the SDG target. An annual reductionof 6.5% is required to achieve the 2030target.

The trend during MDG period is towardsgood decline, but pace is not enough tomeet the SDG target. An annual reductionof 4.5% is required to achieve the 2030target.

The 2030 SDG target is going to beachieved if the current annual reductionrate of 0.7% is maintained.

0.702

UHC and SDGs index: 57% (Makingprogress)

3.3 Communicable diseases

Target 3.3: End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis,water-borne diseases and other communicable diseases

Indicator Baselinevalue (2015)

Current value(2016)

Projected (1)value (2030)

Target value(2030)

ART Coverage (%)

HIV Incidence rate (per100 000 population )

Malaria Incidence rate(per 1 000 population atrisk)

TB Incidence rate (per100 000 population )

Reported number ofpeople requiringinterventions againstNTDs

1,183,042

75

19

86

90

8,477,766

231

168

152

100

11,573,334

391

190

356

65

11,830,416

376

191

855

63

Comment Colourcode (2)

Progress in increasing theantiretroviral coverage is quite good.

The target is likely attainable

An annual reduction of 15.4% isrequired to achieve the 2030 target

An annual reduction of 11% isrequired to achieve the 2030 target

The target is likely attainable.

3.4 Noncommunicable diseases and mental health

Target 3.4. By 2030, reduce by one third premature mortality from noncommunicable diseases through prevention andtreatment and promote mental health and well-being

Indicator Baselinevalue (2015)

Currentvalue (2016)

Projected (1)value (2030)

Target value(2030)

Probability of dying from anyof CVD, cancer , diabetes,CRD between age 30 andexact age 70 (%)

Suicide mortality rate (per100 000 population) 5.76

11.47

3.06

16.24

6.10

17.90

6.40

17.20

Comment Colourcode (2)

The target could likely be achieved.But, an annual reduction of 2.7% isrequired

The target could be achieved if thecurrent trend is reversed and anannual reduction in suicide mortalityrate of 0.7% is applied.

3.5 Substance abuse

Target 3.5: Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful useof alcohol

Indicator Baselinevalue (2015)

Currentvalue (2016)

Projected (1)value (2030)

Target value(2030)

Total alcohol per capita (>=15 years of age)consumption (litres of purealcohol)

4.83.9

Comment Colourcode (2)

Progress in reduction of alcoholconsumption (per capita) is not yetobserved. good.

2

3.7 Sexual and reproductive health

Target 3.7:By 2030, ensure universal access to sexual and reproductive health-care services, including for familyplanning, information and education, and the integration of reproductive health into national strategies and programmes

Indicator Baselinevalue (2015)

Currentvalue (2016)

Projected (1)value(2030)

Target value(2030)

Adolescent birth rate (per1000 women aged 15–19years)

Proportion of married orin-union women ofreproductive age who havetheir need for family planningsatisfied with modernmethods (%)

100.075.7

116.2

63.8

141.0

Comment Colourcode (2)

The pace is not fast enough to meetthe SDG target.

The trend during MDG period istowards substantial decline but thepace is not fast enough to meet theSDG target. An annual reduction ofabout 3.5% is required to achieve the2030 target.

3.8 Universal health coverage

Indicator Baselinevalue (2015)

Currentvalue (2016)

Projected (1)value(2030)

Target value(2030)

UHC Service coverage index 100.056.0

Comment Colourcode (2)

The 2030 SDG target could likely beachieved. But an annual reduction rateof 3.9% is required.

3.d National and global health risks

Target 3.d: Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reductionand management of national and global health risks

Indicator Baselinevalue (2015)

Currentvalue (2016)

Projected (1)value(2030)

Target value(2030)

Compliance withinternational healthregulations

100.0100.092.092.0

Comment Colourcode (2)

The 2030 SDG target is going to beachieved if the current annual reductionrate of 0.6% is maintained.

3.6 Road traffic injuries

Target 3.6: By 2020, halve the number of global deaths and injuries from road traffic accidents

Indicator Baselinevalue (2015)

Currentvalue (2016)

Projected (1)value(2030)

Target value(2030)

Road traffic mortality rate(per 100 000 population) 12.3524.70

Comment Colourcode (2)

The 2030 SDG target is going to beachieved if the current annualreduction rate of 4.7% is maintained.

3

3.9 Mortality from environmental pollution

Target 3.9: By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, waterand soil pollution and contamination

Indicator Baselinevalue (2015)

Currentvalue (2016)

Projected (1)value(2030)

Target value(2030)

Mortality rate attributed tohousehold and ambient airpollution (per 100 000population)

Mortality rate attributed toexposure to unsafe WASHservices (per 100 000population)

Mortality rate from unintentionalpoisoning (per 100 000population)

18.3

2.9

34.9

127.2

3.1

24.5

64.1

Comment Colourcode (2)

The 2030 SDG target could likely beachieved with more effords.

The pace is not fast enough to meetthe SDG target.

Progress in reducing the mortalityrate from unintentional poisoning(per 100 000 population) is quitegood.

16.1 Violence

Target 16.1: Significantly reduce all forms of violence and related death rates everywhere

Indicator Baselinevalue (2015)

Current value(2016)

Projected (1)value (2030)

Target value(2030)

Estimates of rates ofhomicides per 100 000population

8.810.110.2

Comment Colourcode (2)

The 2030 SDG target is going to beachieved.

AARR: Average annual rate of reduction

MDG: Millennium development goals

MMR: Maternal mortality ratio

NNMR: Neonatal mortality rate

SDG: Sustainable development goals

U5MR: Under-five mortality rate

UHC: Universal health coverage

Information, abbreviations and acronyms

Information: Data source: UN inter-agency group for maternal mortality, 2015. WHO,2016.

(1). Projected value is based on the average annual rate of change during the MDG era.(2). Colour codes: Red:No or very slow progress, or decline in performance; Yellow:Good progress but the pace not enough to meet target; Green: Good progress; thepace is enough to meet or surpass the SDG target.

Method of calculation of the UHC and SDGs index:Values 0, 1 and 2 are assigned to Red, Yellow and Green colour, respectively. For the22 indicators followed, the sum of the points obtained for each country is calculated andthese points are matched to the percentage scale as follows:44 points (maximum) = 100%

4

Demographic and socioeconomic statistics

Population (inthousands) total

Population proportionunder 15 (%)

Population proportionover 60 (%)

Population median age(years)

Population living on<$1 (PPP int. $) a day

(%)

Rural population (% oftotal population)

2007-2013

2010

2011

2012

2013

2014

2015

2016

2017 58

59

59

60

60

60

61

61

74

17

17

24516,591

Population (Data source: WHO and World Bank 2018)

Life expectancy at birth (years)

Both sexes Female Male

Life expectancy at age 60 (years)

Bothsexes

Female Male

Healthy life expectancy (HALE) atbirth (years)

Both sexes Female Male

Healthy life expectancy (HALE) atage 60 (years)

Bothsexes

Female Male

2010

2011

2012

2013

2014

2015

2016 60.2

59.8

59.3

58.5

57.7

56.7

55.7

64.4

63.6

63.1

62.3

61.5

60.5

59.3

62.3

61.7

61.2

60.5

59.6

58.6

57.5

16.6

16.5

16.5

16.4

16.3

16.1

16

18.3

18.1

18.1

17.9

17.8

17.6

17.4

17.5

17.4

17.4

17.2

17.1

16.9

16.7

52.6

52.2

48.7

56

55.4

51.5

54.3

53.8

50.1

11.9

11.9

11.4

13.4

13.3

12.7

12.7

12.7

12.2

Life expectancy (Data source: WHO 2018)

2010 2011 2012 2013 2014 2015 2016

10

20

30

40

50

Number per 1,000 people

10.19.6 9.1 8.6

39.139.5 38.8

40.4

8.3

38.1

7.88.0

38.439.9

Crude birth and death rates (per 1,000 people) (Data source: WHO 2018)

Birth Death

5

2010 2016

Infectious and parasitic diseases

Respiratory Infectious

Neonatal conditions

Nutritional deficiencies

Maternal conditions 11

29

40

93

383

18

34

48

112

558

Age-standardized death rate per 100 000 population by communicablediseases groups (Data source: WHO 2018)

Self-harm11

Road injury35

Other unintentionalinjuries13

Interpersonal violence11

Fire, heat and hotsubstances6

Falls18 Exposure

to

Drowning6

Age-standardized death rate per 100 000 population by injuries in 2016(Data source: WHO 2018)

Communicable, maternal,perinatal and nutritionalconditions

Noncommunicable diseases

Injuries

556

770

554

592

107

115

Age-standardized death rate per 100 000 population by broadercauses (Data source: WHO 2018)

2010 2016

Cardiovascular diseases

Malignant neoplasms

Digestive diseases

Respiratory diseases

Neurological conditions

Diabetes mellitus

Genitourinary diseases

Congenital anomalies

Endocrine, blood, immune disorders

Skin diseases

Other neoplasms

Mental and substance use disorders

Musculoskeletal diseases

Oral conditions

Sense organ diseases

1

2

5

6

6

9

16

26

28

33

68

123

230

1

2

5

5

7

9

17

27

26

36

74

129

254

Age-standardized death rate per 100 000 population bynoncommunicable diseases groups (Data source: WHO 2018)

2010 2011 2012 2013 2014 2015 2016

100

200

300

400

500

Probability of dying between 15 and 60 years per 1000

population

324330334

347

364

382403

327

304290

277266 261

250

Adult mortality rate (Data source: WHO 2018)

Mortality and morbidity

Female

Male

Year2010

2016

6

Maternal and Reproductive Health

Maternal mortality ratio

2000 2005 2010 2015 2020 2025 20300

100

200

300

400

500

Deaths per 100 000 live births

150

100 67

224

185152

126

541

372

262

Condoms use

Maternal mortality ratio (per 100 000 live births)Projections of MMR based on the current AARR of 3.8%Projections of MMR based on the AARR of 7.8% needed to reach the target

Prevention of mother-to-child transmission(PMTCT)

2011-2016

Condom use amongadolescents withmultiple partners (%)

Female

Male 38

33

2007-2013

Prevalence of Condomuse by adults aged15-49 years athigher-risk sex (%)

Female

Male 28

33

2008

2009

2010

2011

2012

2013

2015

2016

30

40

50

60

70

80

90

100

Percent

59

69 75

86

96

76

87

83

2010-2015

Antenatal care coverage - at least fourvisits (%) 56

2012

Incidence rate (per 100, 000population)

Cumulative risk Incidence (per 100,000 population),

Mortality rate (per 100, 000population)

Cumulative risk Mortality(per 100, 000population) 4

20

6

34

Antenatal care

Cervical cancer screening

7

Child health and nutritionImmunization (Data source: WHO, 2017)

Child nutrition (Data source: WHO, 2015)

Low birth-weight prevalence (%) 2000-2015

Stunting prevalence (%) 2000-2015

Overweight prevalence (%) 2000-2015

Wasting prevalence (%) 2000-2015

Exclusive breastfeeding < 6 months (%) 2000-2015

Prevalence of anaemia in pregnant women (hb <11g/dL)

2000-2015

9.2

40

6.2

6.3

72.5

38.3

2010 2011 2012 2013 2014 2015 2016 20170

10

20

30

40

50

60

70

80

90

100

Percent

90

8580

93

9696

83

82

MCV immunization coverage among 1-year-olds (%)

2010 2011 2012 2013 2014 2015 2016 20170

10

20

30

40

50

60

70

80

90

100

Percent

86

83

94

81

78

90

79

91

Penta 3 immunization coverage among 1-year-olds (%)

2010 2011 2012 2013 2014 2015 2016 20170

10

20

30

40

50

60

70

80

90

100

Percent

95 979292

92999999

BCG immunization coverage among 1-year-olds (%)

2010 2011 2012 2013 2014 2015 2016 20170

10

20

30

40

50

60

70

80

90

100

Percent

83

80

70

78

92

87

90

74

Polio immunization coverage among 1-year-olds (%)

Penta 3 Penta 1 Dropout rate

2017

2016

2015

2014

2013

2012

2011

2010 -9

-6

-8

-7

-10

-7

-8

-1

92

87

86

86

96

97

99

95

83

81

78

79

86

90

91

94

Penta1-Penta3 dropout rateAvailability of childhood immunization services inhealth facilities 2012-2016

Fully immunized children aged 12-23 months 2010-2015

89

68.3

8

Newborn and Child Health

Child mortality rate

2000 2005 2010 2015 2016 2020 2025 20300

20

40

60

80

100

120

140

160

Deaths per 1 000 live births

23

19 1512

2119

18

37

3027

23

63

48

34

25

54

44

35

161

110

83

66

Under-five mortality rateProjections of U5MR based on the current AARRProjections based on the AARR needed to reach the SDG targeNeonatal mortality rateProjections of NNMR based on the current AARRProjections of NNMR based on the AARR needed to reach the SDG target

2005-2008 2011-2016

Diarrhoea (%)

Fever (%)

Pneumonia (%) 70

75

64

68

43

56

Care Seeking

2011-2016

Early initiation (%)

Exclusive breastfeeding <6months (%) 73

66

Breastfeeding

Hepatitis B prevalence

2015

Hepatitis B surface antigen (HBsAg) prevalenceamong children under 5 years (%) 2

9

Communicable diseases

HIV epidemic (Data source: WHO 2018)

2010 2011 2012 2013 2014 2015 2016 2017

0

500,000

1,000,000

1,500,000 1,100,0001,100,0001,000,000970,000

1,100,0001,100,0001,000,000940,000

Number of people living with HIV

2010

2011

2012

2013

2014

2015

2016

2017

0

5

10

15

11.511.81212.112.212.312.312.3

Prevalence of HIV among adults aged 15 to49 (%)

2010 2011 2012 2013 2014 2015 2016 2017

0

10,000

20,000

30,000

16,00016,00017,00017,00019,00020,00023,000

25,000

Number of deaths due to HIV

2010 2011 2012 2013 2014 2015 2016 2017

0

20,000

40,000

60,000

48,00050,00053,00058,00061,00060,00061,00063,000

Number of new HIV infections

2010

2011

2012

2013

2014

2015

2016

2017

0

2

4

6

8

10

3.63.864.19

4.574.814.915.115.35

Number of new HIV infections (per 1000uninfected population)

HIV responses (Data source: WHO 2018)

2012 2014

Number of testing and counselling facilities

Number of testing and counselling facilities per 100 000 adult population

Number of people aged 15 years and over who received HIV testing and counselling

Estimated number of people aged 15 years and over who received HIV testing and counselling per 1000 adultpopulation

2,453,242

22

1,765

270

HIV testing and counselling

2010 2011 2012 2013 2014 2015 2016 2017

0

200,000

400,000

600,000

800,000

1,000,000

Number of people under ART

325,000

396,000

446,000

521,000

609,000

707,000

747,000

804,000

24,200

28,200

33,700

39,100

44,200

51,900

50,600

46,100

Number of HIV people receiving antiretroviral therapy (ART) byclass of ages

2010 2011 2012 2013 2014 2015 2016 2017

0

20

40

60

80

100

Percent

37

4448

54 61

70

72

75

38

4448

5562

7072

76

30

3543

50

57

69 6964

Percent of HIV people receiving ART by class of ages

0-14 years old

15 years old and over

0-14 years old

15 years old and over

All ages

10

2010 2011 2012 2013 2014 2015 2016 2017

0

100,000

200,000

300,000

400,000

500,000

Number of people

127,000

156,000

188,000216,000

237,000

272,000286,000

298,000

198,000

240,000

258,000

305,000

373,000

435,000 461,000

506,000

Number of HIV people aged 15 and over receivingantiretroviral therapy by sex

2010 2011 2012 2013 2014 2015 2016 2017

0

20

40

60

80

100

Percent

3743

50

5659

6668 70

39

4547

54

63

7274

80

Percent of HIV people aged 15 and over receivingantiretroviral therapy by sex

Female Male Both sexes

HIV Incidence (%) 15-49 years

15-59 years

HIV prevalence (%) 0-14 years

15-49 years

Urban areas

Rural areas

15-59 years

Viral load suppression (%) 0-14 years

15-59 years

People living with HIV (PLHIV) aged 15 to 64 were aware of their HIV status (%)

PLHIV aged 15 to 64 who knew their HIV status and were on ART (%)

PLHIV aged 15 to 64 currently use of ART and were virally suppressed (%)

0.66

0.7

0.33

0.33

1

1.08

12.3

11.6

1.3

9.5

8.6

14.9

14.5

59.857.561.3

67.362.870

85.486.284.9

89.288.289.7

Viral load suppression (Data source: Ministry of Health, 2017)

Medically circumcised Non-medically circumcised Uncircumcised Unknown

Prevalence of voluntary medical male circumcision (No data)

Female Male

Condom at last sex with non-marital partner among those who reported having sex with a non-marital, non-cohabitingpartner in the past 12 months (%)

Sex with non-marital partner in 12 months among those who reported having sex in the past 12 months (%)

Prevalence of sex with non-marital partner and condom use at last sex (No data)

2015 2016 2017

Percent of people living with HIV who know their status

Percent of people who know their status who are on ART

Percent of people on ART who achieve viral suppression

9696

83

7272

Progress towards 90-90-90 targets (Data source: UNAIDS 2018)

Female

Male

Female

Male

11

TB treatment coverage (Data source: WHO 2018)

Tuberculosis - new and relapse cases

2010 2011 2012 2013 2014 2015 2016

0

20,000

40,000

60,000

Number of cases

44,154

43,583

40,726

40,638

37,931

36,741

38,326

Tuberculosis treatment coverage (%)

2010 2011 2012 2013 2014 2015 2016

0

50

100

Percent

6464

61

61 60

58

62

2010 2011 2012 2013 2014 2015 2016

New cases: extrapulmonary

New cases: Pulmonary, smear-negative/unknown/not done and other newcases

New cases: Pulmonary, smear-positive

New or unknown treatment history cases: Pulmonary, bacteriologicallyconfirmed

New or unknown treatment history cases: Pulmonary, clinically diagnosed

Treatment history unknown

13,727

13,739

6,150

14,779

12,311

7,754

15,568

12,070

8,584

17,167

12,238

9,370

12,645

17,050

9,174

12,046

20,004

9,908

0

12,639

20,412

9,255

TB new case notifications (Data source: WHO 2018)

2010 2011 2012 2013 2014 2015 2016

Number of incident tuberculosis cases

Incidence of tuberculosis (per 100 000population per year)

Number of incident tuberculosis cases(HIV-positive cases)

Incidence of tuberculosis (per 100 000population) (HIV-positive cases)

218

36,000

376

62,000

233

38,000

391

63,000

247

39,000

406

63,000

268

41,000

437

66,000

281

41,000

456

67,000

316

45,000

475

68,000

348

48,000

495

69,000

TB incidence (Data source: WHO 2018)

Number of deaths due to tuberculosis, excluding HIV

2010

2011

2012

2013

2014

2015

2016

0

1,000

2,000

3,000

4,000

5,000

6,000

Number of deaths 3,500

3,900

4,800

4,700

4,800

5,000

4,800

Deaths due to tuberculosis among HIV-negative people (per 100000 population)

2010

2011

2012

2013

2014

2015

2016

0

20

40

60

80

100

Number of deaths per 100 000 population

25 28

33

31 30

3129

TB mortality (Data source: WHO 2018)

12

2010 2011 2012 2013 2014 2015 2016

Previously treated cases, excluding relapse

Relapse cases: extrapulmonary

Relapse cases: Pulmonary, bacteriologicallyconfirmed

Relapse cases: Pulmonary, clinicallydiagnosed 2,190

1,906

614

1,827

1,897

4,847

1,709

4,785

1,863

5,1554,5515,0114,462

TB previously treated case notifications (Data source: WHO 2018)

2010 2011 2012 2013 2014 2015 2016

Confirmed cases of RR-/MDR-TB (1)

Cases started on MDR-TB treatment

New cases tested for RR-/MDR-TB (%)

Previously treated cases tested forRR-/MDR-TB (%)

Estimated MDR/RR-TB cases among notifiedpulmonary TB cases

1,400

7.1

0.15

136

180

9.2

0.22

99

196

79

79

97

80

TB Drug resistance (Data source: WHO 2018)

(1) MDR: Multi-drug resistant; RR: Rifampicin-resistant

2010 2011 2012 2013 2014 2015 2016

50

100

150

Percent

48 53 60

6773

76 83

65 64 61

62 61 60 58

84

86

87 90

93 95 93

Co-epidemics of TB and HIV (Data source: WHO 2018)

TB treatment success (Data source: WHO 2018)

2010 2011 2012 2013 2014 2015 2016

40

60

80

100

120

Percent

79 80 8084

8988

85 85 85 85

64 64 61 61 60 58 62

2010 2011 2012 2013 2014 2015 2016

0

50

100

150

Percent

87

36

29 2733

51

TB patients with known HIV status (%)

Tested TB patients HIV-positive (%)

HIV-positive TB patients on antiretroviral therapy (%)

Tuberculosis treatment coverage (%)

Treatment success rate: new TB cases (%)

Treatment success rate: previously treated TB cases (%)

Treatment success rate for patients treated for MDR-TB (%)

Treatment success rate: HIV-positive TB cases (%)

13

2012 2013 2014 2015 2016 2007-2013 2013-2014

Estimated malaria cases

Number of malaria cases per 100,000population at risk

Estimated malaria deaths

Malaria mortality rate per 100,000 population

Children aged <5 years sleeping underinsecticide-treated nets (%)

Proportion of children under 5 years of age withfever being treated with antimalarial drugs

41

37

42

7,000

18,980

3,149,000

19,148

3,083,000

21,446

3,350,000

21,712

3,290,000

17,653

2,595,000

Malaria cases and deaths (Data source: WHO 2017)

2010 2015

Number of insecticide classes to which resistance was reportedNo class 2 classes

Insecticide class resistance (Data source: WHO 2017)

2012 2013 2014 2015 2016 2017

Leprosy - number of reported cases

Number of cases of visceral leishmaniasis reported

Number of new reported cases of human africantrypanosomiasis (T.b. rhodesiense)

Number of people operated for trachomatous trichiasis

Number of people who received treatment with antibiotics fortrachoma

Estimated number of individuals in the country requiringpreventive chemotherapy for onchocerciasis

Reported number of individuals treated for onchocerciasis

5,591,160

596

4,034,352

1,829

2

3,223,750

1,100

8

1,351,164

1,474

12

1,651,316

6

0

2,063,652

6

0

Neglected tropical diseases cases and deaths (Data source: WHO 2018)

14

2013 2016 2018

Status of endemicity of onchocerciasis

Status of endemicity of visceral leishmaniasis

Status of endemicity of cutaneous leishmaniasis

Status of bejel endemicity

Status of elimination of trachoma as a public health problem

Status of yaws endemicityPreviously endemic (currentstatus unknown)

No previous history of bejel

No data

No autochthonous casesreported

Known to require interventions

Endemic

Neglected tropical diseases status of endemicity (Data source: WHO 2018)

2010 2011 2012

Number of reported cases of cholera

Number of reported deaths from cholera

Cholera case fatality rate (%) 1

2

198

2

7

330

1

62

6,794

Cholera cases and deaths (Data source: WHO 2018)

2010 2011 2012 2013 2014

Number of suspected meningitis deaths reported

Meningitis cases and deaths (No data)

2010 2011 2012 2013 2014 2015 2016 2017

Women accessing antenatal care (ANC) services who weretested for syphilis (%)

Antenatal care attendees who were positive for syphilis (%)

Antenatal care attendees positive for syphilis who receivedtreatment (%)

Sex workers with active syphilis (%) 19

100

56

100

3.5

82.1

3.6

38.8

100

4.6

50.2

100

36.327.6

100

4.7

43.3

Syphilis (Data source: WHO 2018)

15

Noncommunicable diseases

2010 2011 2012 2013 2014 2015 201614

16

18

20

22

24

26

28

30

32

34

36

38

Value

32.132.8

33.534.2

34.935.6

36.3

16.6 16.9 17.3 17.7 18.2 18.6 19.0

Adults ≥ 18 years who were overweight, by sex (%)

2010 2011 2012 2013 20140

10

20

30

40

50

60

70

80

90

100

Percent

6.3 6.46.6

6.26.1

Adults ≥18 years with raised fasting blood glucose (%)

2010 2011 2012 2013 2014 20150

10

20

30

40

50

60

70

80

90

100

Percent

27.3

27.327.127.5

27.227.4

Adults ≥18 years with raised blood pressure (%)

2010 2011 2012 2013 2014 201526.2

26.4

26.6

26.8

27.0

27.2

27.4

27.6

27.8

28.0

Percent

26.926.8

26.726.6 26.6

26.5

28.027.9

27.8 27.827.7

27.6

Adults ≥18 years with raised blood pressure, by sex (%)

2010 2011 2012 2013 2014

5.8

5.9

6.0

6.1

6.2

6.3

6.4

6.5

6.6

6.7

6.8

Percent

6.2

6.3

6.6

5.9

6.0

6.2

6.3

6.5

Adults ≥18 years with raised fasting blood glucose, by sex(%)

2010 2011 2012 2013 2014 2015 20160

10

20

30

40

50

60

70

80

90

100

Percent

26.1

25.6

26.7

27.8

24.5 25.0

27.3

Adults ≥ 18 years who were overweight (%)

Female

Male

Female

Male

Female

Male

16

2010 2011 2012 2013 2014 20150

10

20

30

40

50

60

70

80

90

100

Percent

2.8 2.92.92.93.0

3.0

Per capita alcohol consumption among people ≥15 years(%)

2010 2011 2012 2013 2014 2015 20160

10

20

30

40

50

60

70

80

90

100

Percent

7.1 7.48.1

6.86.3

7.76.5

Adults ≥ 18 years who were obese (%)

2010 2011 2012 2013 2014 2015 2016

2

4

6

8

10

12

Percent

10.210.6

11.111.5

12.012.4

9.8

2.6 2.7 2.9 3.0 3.2 3.4 3.6

Adults ≥ 18 years who were obese, by sex (%)

Female MaleBothsexes

Percent individuals ≥15 years whoused tobacco 2015

Percent of adults ≥ 18 years withinsufficient physical activity

2010

Percentage of adults ≥ 25 years withraised cholesterol 2008

9.617.22.2

20.517.323.7

27.726.528.5

Female

Male

17

Health systems and services

Service availability and readiness (Data source: SARA surveys 2013-2017)

Basic amenities Basic equipment Diagnostics Essential medicines Standard precautions forinfection prevention and

control

General ServiceReadiness Index

0

50

100

Percent

71

89

43

66

87

71Index

Readiness to provide general services, 2013

Adolescent health services

Antenatal care

ART

Basic obstetric care

Basic surgery

Blood transfusion

Cardiovascular diseases

CEmOC

Cervical cancer screening

Child immunization

Chronic obstructive respiratory disease

Comprehensive surgery

Diabetes

Family planning

HIV care and support

HIV counselling and testing

Malaria

PMTCT

Preventive & curative services

STIs

TB 62

100

95

89

100

97

75

87

58

24

73

89

9

95

72

11

73

69

66

90

62

Percent of facilities that reported offering services, byservices type, 2013

Adolescent health services

Advanced diagnostic services

Antenatal care

ART

Basic obstetric care

Basic surgery

Blood transfusion

Cardiovascular diseases

CEmOC

Cervical cancer screening

Child immunization

Chronic obstructive respiratory disease

Comprehensive surgery

Diabetes

Family planning

High-level diagnostic services

HIV care and support

HIV counseling and testing

Life-saving medicine (children)

Life-saving medicines (mothers)

Malaria

PMTCT

Preventive and curative services for under-fives

STIs

TB 62

66

73

71

72

43

86

72

51

73

58

85

43

77

62

59

52

61

49

67

55

75

67

58

The mean availabity of items for offering the specificservices (%), 2013

Service availability index 71

Health financing (Data source: WHO 2018)

2010 2011 2012 2013 2014 20150

20

40

60

US$

46.2 53.0

19.2

37.6

60.8

74.2

Domestic General Government Health Expenditure (cGGHE-D) perCapita in PPP Int$

2010 2011 2012 2013 2014 20150

2

4

6

8

10

12

14

16

Percent

5.7

3.3

6.0

6.0

6.4 6.8

Current Domestic General Government Health Expenditure(cGGHE-D) as % General Government Expenditure (GGE)

18

Health financing (Data source: WHO 2018)

2010 2011 2012 2013 2014 2015010

20

30

40

50

60

70

80

90

10013.0

23.2 27.5 29.5 31.7 36.6

47.9

46.845.3 43.4 42.2

39.2

39.130.0 27.2 27.1 26.1 24.3

Break down of Total Currente Health Expenditure by source (%)

2010 2011 2012 2013 2014 201505

10

15

20

25

30

35

40

4550

US $

30.7

32.0

27.5

29.733.0

33.9

Out-of-pocket (OOPS) as % of Total Current Health Expenditure(CHE)

Currente Domestic General Government Health Expenditure (GGHE-D) as % Total Current Health Expenditure (CHE)

Domestic Private Health Expenditure (PVT-D) as % Current Health Expenditure (CHE)

External Health Expenditure (EXT) as % of Current Health Expenditure (CHE)

2010 2011 2012 2013 2014 2015

Current Health Expenditure (CHE) as % Gross Domestic Product (GDP)

Domestic General Government Health Expenditure (GGHE-D) as % Gross Domestic Product (GDP)

External Health Expenditure Channelled through Government (EXT-G) as % of External HealthExpenditure (EXT)

Domestic Health Expenditure (DOM) as % of Current Health Expenditure (CHE)

Current Health Expenditure (CHE) per Capita in PPP

Domestic Private Health Expenditure (PVT-D) per Capita in PPP Int$

External Health Expenditure (EXT) per Capita in PPP Int$

Current Health Expenditure (CHE) per Capita in US$

Domestic General Government Health Expenditure (GGHE-D) per Capita in US$

Domestic Private Health Expenditure (PVT-D) per Capita in US$

External Health Expenditure (EXT) per Capita in US$ 16.8

27.2

25.4

69.4

49.3

79.5

203.0

75.7

47.4

2.0

5.4

22.7

36.7

27.6

87.1

50.0

80.9

191.7

73.9

47.1

1.6

5.1

24.4

39.0

26.5

89.9

48.7

78.0

179.8

72.9

52.9

1.5

5.1

22.2

37.0

22.4

81.6

45.8

76.2

168.1

72.8

49.3

1.3

4.8

23.8

37.1

18.4

79.3

48.6

75.9

162.1

70.0

43.3

1.1

4.6

26.3

32.3

8.8

67.4

57.8

70.9

147.9

60.9

56.2

0.6

4.6

Health workforce (Data source: WHO 2018)

2008 2009 2010 2011 2012 2016

Physicians density (per 1000 population)

Nursing and midwifery personnel density (per 1000 population)

Other health workers density (per 1000 population) 0.15

0.89

0.09

0.26

0.16

0.25

0.16

1.01

0.71

0.06

1.03

0.70

0.06

0.09

0.69

0.06

Medical products, infrastructures and equipment (Data source: WHO 2018)

Private Public

Median availability of selected generic medicines (%)*

Median consumer price ratio of selected generic medicines**

74

4.7

81.3

Essential medicines, 2007-2013

Availability of technical specifications of medical devices to support procurement or donations

Availability of national list of approved medical devices for procurement or reimbursement

Availability of national standards or recommended lists of medical devices

National guidelines, policies or recommendations on the procurement of medical devices

Yes, but it is only a recommendation

Yes

Yes

For different healthcare facilities and specific procedures

*Median percentage availability of selected generic medicinesin a samble of heath facilitie

**Median consumer price ratio of selected generic medicines(ratio of median local unit price to management sciences forhealth international reference price), countries with data

19

Medical products, infrastructures and equipment (Data source: WHO 2018)

2010 2013

Hospitals

District/rural hospitals

Provincial hospitals

Specialized hospitals

Health centres

Health posts 1.18

8.33

0.03

0.12

0.30

0.45

1.31

9.25

0.04

0.14

0.33

Infrastructures: Total density per 100 000 population

2011 2014

Beds for mental health in general hospitals (per100,000)

Beds in mental hospitals (per 100,000) 1.997

1.997

1.58

1.51

Beds density

2008 2010

Hospital beds (per 10 000 population) 8038

2010 2013 2014

Total density per million females aged from 50 to 69years old: Mammography units

Total density per million population: Computedtomography units

Total density per million population: Gamma cameraor Nuclear medicine

Total density per million population: LinearAccelerator

Total density per million population: MagneticResonance Imaging

Total density per million population: PositronEmission tomography

Total density per million population: Radiotherapyunits

Total density per million population: Telecobalt Unit

4.56

0.07

0.14

0.00

0.07

0.07

0.07

0.21

0.08

0.15

0.00

0.08

0.08

0.08

0.23

4.09

Equipment

Health information, evidence and knowledge

Census carried out in the 2010 round of censuses (2005-2014)

Census carried out in the 2020 round of censuses (2015-2024)

No census taken or planned in the period indicated

It is expected that a census will be held on the date indicated

Census carried out (Data source: UNSD 2016)

2017

Cause of Death Reporting at Health Facilities (%): with MCCoD/ICD Compliance

Civil registration coverage of births (%) 11.3

4

Civil registration (Data source: WHO, 2018)

2010 2011 2012 2013 2014 2015 2016 2017

Cellular or mobile subscribers per 100 inhabitants

Percentage of individuals using the Internet

78.6

25.5

72.4

21.0

71.8

19.0

64.8

15.4

68.6

13.5

71.6

11.5

57.2

10.0

39.3

eHealth (Data source: ITU, 2018)

20

Social determinants of healthWater and sanitation (Data source : WHO, 2015)

2010 2011 2012 2013 2014 2015 20160

10

20

30

40

50

60

70

80

90

100

Percent 58.857.7

49.8

61.5

67.7

56.762.0

3.42.7

3.23.53.1

3.8 3.7

Population with access to electricity, by residence area (%)

1990 2000 20150

10

20

30

40

50

60

70

80

90

100

Percent

40.6 40.643.9

Population using improved sanitation (%)

1990 2000 20150

10

20

30

40

50

60

70

80

90

100

Percent

49.2

65.4

53

Population using improved drinking water source (%)

1990 2000 2015

Rural Urban Rural Urban Rural Urban0

10

20

30

40

50

60

70

80

90

100

Percent

23.6

88.4

34.7

87.3

51.3

85.6

Population using improved drinking water source, byresidence area (%)

1990 2000 2015

Rural Urban Rural Urban Rural Urban0

10

20

30

40

50

60

70

80

90

100

Percent

28.6

58.9

31.5

57.6

35.7

55.6

Population using improved sanitation, by residence area(%)

Access to electricity (Data source : World Bank, 2015)

2010 2011 2012 2013 2014 2015 20160

10

20

30

40

50

60

70

80

90

100

Percent

25.5

31.1

27.224.922.0

27.924.3

Population with access to electricity (%)

Rural

Urban

21